LivaNova (LIVN) Interest Expenses (2014 - 2026)
LivaNova (LIVN) posted Interest Expenses of $64.8 million for Q1 2026, up 980.32% sequentially from -$7.4 million in Q4 2025, and up 323.92% YoY from $15.3 million in Q1 2025.
LivaNova (LIVN) Interest Expenses (2014 - 2026) Analysis & Trends
LivaNova has reported Interest Expenses for 13 years, with the latest figure at $64.8 million in Q1 2026.
- Quarterly Interest Expenses rose 323.92% year-over-year to $64.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.8 million (up 3.74% YoY) and the FY2025 annual result came in at $127.6 million, down 19.66% from the prior year.
- Interest Expenses climbed to $64.8 million in Q1 2026 per LIVN's latest filing, from -$7.4 million in the prior quarter.
- Over five years, Interest Expenses peaked at $64.8 million in Q1 2026 and troughed at -$7.4 million in Q4 2025.
- A 5-year average of $15.6 million and a median of $14.8 million in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2025 and 2026: Interest Expenses slumped 146.69% in 2025, then surged 323.92% in 2026.
- Over 5 years, Interest Expenses stood at $13.4 million in 2022, then rose by 16.91% to $15.6 million in 2023, then grew by 0.93% to $15.8 million in 2024, then sank by 146.69% to -$7.4 million in 2025, then soared by 980.32% to $64.8 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $64.8 million, -$7.4 million, and $10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 129.56 Bn | 126.08 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 120.09 Bn | 110.87 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 73.80 Bn | 73.26 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.12 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 15.80 Mn |
| 10 | LivaNova | 4.35 Bn | 3.83 Bn | 273.67 Mn | 7.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.10 Mn |
| Jun 30, 2026 | 60.10 Mn |
| Mar 31, 2026 | 64.80 Mn |
| Mar 31, 2026 | 64.80 Mn |
| Dec 31, 2025 | -7.36 Mn |
| Dec 31, 2025 | -7.36 Mn |
| Sep 30, 2025 | 10.86 Mn |
| Sep 30, 2025 | 10.86 Mn |
| Jun 30, 2025 | 12.28 Mn |
| Jun 30, 2025 | 12.28 Mn |
| Mar 31, 2025 | 15.29 Mn |
| Mar 31, 2025 | 15.29 Mn |
| Dec 31, 2024 | 15.77 Mn |
| Dec 31, 2024 | 15.77 Mn |
| Sep 30, 2024 | 15.88 Mn |
| Sep 30, 2024 | 15.88 Mn |
| Jun 30, 2024 | 15.53 Mn |
| Jun 30, 2024 | 15.53 Mn |
| Mar 31, 2024 | 15.89 Mn |
| Mar 31, 2024 | 15.89 Mn |